Caixin
Sep 03, 2022 06:31 AM
BUSINESS

Livzon Pharmaceutical Covid Shot Wins China Approval

What’s new: China approved another Covid-19 vaccine for emergency use as the country continues its stringent virus-control policy with two more megacities under lockdown.

A Covid vaccine created by Livzon Pharmaceutical Group Inc. (000513.SZ) Friday became the eighth domestically developed shot approved for use in China. It will be used as a booster as nearly 90% of the country’s 1.4 billion population have received primary vaccinations.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin-Sinica Business Brief: China Mourns Death of Former President Jiang Zemin
00:00
00:00/00:00